FDA Moves To Limit Fluoride In Children’s Ingestible Products, Citing Gut Health Concerns

The U.S. Food and Drug Administration announced plans to reduce the amount of fluoride present in ingestible children’s products.

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s ...

FDA flags cholesterol drug for possible effectiveness issues

The Food and Drug Administration has initiated a Class II recall of 141,984 bottles of atorvastatin calcium after tests ...
STAT

FDA digital advisers confront risks of therapy chatbots, weigh possible regulation

FDA's digital advisors could nudge the agency to clarify how its rules apply to medical applications of generative AI, ...

Former Stanford professor accused of 'reprehensible' conduct quits top FDA job

Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...

CT company recalls pasta sauces sold at Big Y and Stop & Shop due to food poisoning risk, FDA says

Sales and production of the sauces made by First and Last Bakery have been suspended to ensure compliance with regulations, ...

Dr. Oz and FDA chief say biosimilar drug reform will lower prices

Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...

FDA announces plans to relax rules about copycat drugs

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...

FDA recalls 580K bottles of this blood pressure medication: Is your medicine on the list?

The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...